129 related articles for article (PubMed ID: 9779467)
21. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
Dutta AK; Xu C; Reith ME
J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474
[TBL] [Abstract][Full Text] [Related]
22. Discovery of a novel dopamine transporter inhibitor, 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone, as a potential cocaine antagonist through 3D-database pharmacophore searching. Molecular modeling, structure-activity relationships, and behavioral pharmacological studies.
Wang S; Sakamuri S; Enyedy IJ; Kozikowski AP; Deschaux O; Bandyopadhyay BC; Tella SR; Zaman WA; Johnson KM
J Med Chem; 2000 Feb; 43(3):351-60. PubMed ID: 10669562
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationship studies of N-sulfonyl analogs of cocaine: role of ionic interaction in cocaine binding.
Kozikowski AP; Saiah MK; Bergmann JS; Johnson KM
J Med Chem; 1994 Sep; 37(20):3440-2. PubMed ID: 7932572
[TBL] [Abstract][Full Text] [Related]
24. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.
Shimada S; Kitayama S; Lin CL; Patel A; Nanthakumar E; Gregor P; Kuhar M; Uhl G
Science; 1991 Oct; 254(5031):576-8. PubMed ID: 1948034
[TBL] [Abstract][Full Text] [Related]
25. Delineating structure-function relationships in the dopamine transporter from natural and engineered Zn2+ binding sites.
Gether U; Norregaard L; Loland CJ
Life Sci; 2001 Apr; 68(19-20):2187-98. PubMed ID: 11358327
[TBL] [Abstract][Full Text] [Related]
26. The effects of phosphorylation on the functional regulation of an expressed recombinant human dopamine transporter.
Vrindavanam NS; Arnaud P; Ma JX; Altman-Hamamdzic S; Parratto NP; Sallee FR
Neurosci Lett; 1996 Sep; 216(2):133-6. PubMed ID: 8904801
[TBL] [Abstract][Full Text] [Related]
27. Cloning and expression of a cocaine-sensitive rat dopamine transporter.
Kilty JE; Lorang D; Amara SG
Science; 1991 Oct; 254(5031):578-9. PubMed ID: 1948035
[TBL] [Abstract][Full Text] [Related]
28. Cloning and functional characterization of a cocaine-sensitive dopamine transporter.
Giros B; el Mestikawy S; Bertrand L; Caron MG
FEBS Lett; 1991 Dec; 295(1-3):149-54. PubMed ID: 1765147
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and ligand binding studies of 4'-iodobenzoyl esters of tropanes and piperidines at the dopamine transporter.
Singh S; Basmadjian GP; Avor KS; Pouw B; Seale TW
J Med Chem; 1997 Aug; 40(16):2474-81. PubMed ID: 9258354
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the human dopamine transporter heterologously expressed in BHK-21 cells.
Lenhard T; Marheineke K; Lingen B; Haase W; Hammermann R; Michel H; Reiländer H
Cell Mol Neurobiol; 1998 Jun; 18(3):347-60. PubMed ID: 9590564
[TBL] [Abstract][Full Text] [Related]
31. Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: methodology and mechanistic interpretations.
Earles C; Wayment H; Green M; Schenk JO
Methods Enzymol; 1998; 296():660-75. PubMed ID: 9779481
[No Abstract] [Full Text] [Related]
32. Molecular pharmacology of cocaine: a dopamine hypothesis and its implications.
Kuhar MJ
Ciba Found Symp; 1992; 166():81-9; discussion 89-95. PubMed ID: 1638923
[TBL] [Abstract][Full Text] [Related]
33. The region of dopamine transporter encompassing the 3rd transmembrane domain is crucial for function.
Lee SH; Kang SS; Son H; Lee YS
Biochem Biophys Res Commun; 1998 May; 246(2):347-52. PubMed ID: 9610361
[TBL] [Abstract][Full Text] [Related]
34. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
[TBL] [Abstract][Full Text] [Related]
35. Mutational scanning of the human serotonin transporter reveals fast translocating serotonin transporter mutants.
Kristensen AS; Larsen MB; Johnsen LB; Wiborg O
Eur J Neurosci; 2004 Mar; 19(6):1513-23. PubMed ID: 15066148
[TBL] [Abstract][Full Text] [Related]
36. Characterization of dopamine transporter and locomotor effects of cocaine, GBR 12909, epidepride, and SCH 23390 in C57BL and DBA mice.
Womer DE; Jones BC; Erwin VG
Pharmacol Biochem Behav; 1994 Jun; 48(2):327-35. PubMed ID: 8090798
[TBL] [Abstract][Full Text] [Related]
37. Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter.
Chen N; Ferrer JV; Javitch JA; Justice JB
J Biol Chem; 2000 Jan; 275(3):1608-14. PubMed ID: 10636852
[TBL] [Abstract][Full Text] [Related]
38. 3-Aryl-2-(3'-substituted-1',2',4'-oxadiazol-5'-yl)tropane analogues of cocaine: affinities at the cocaine binding site at the dopamine, serotonin, and norepinephrine transporters.
Carroll FI; Gray JL; Abraham P; Kuzemko MA; Lewin AH; Boja JW; Kuhar MJ
J Med Chem; 1993 Oct; 36(20):2886-90. PubMed ID: 8411004
[TBL] [Abstract][Full Text] [Related]
39. 3 alpha-(4'-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters: novel ligands with high affinity and selectivity at the dopamine transporter.
Holmquist CR; Keverline-Frantz KI; Abraham P; Boja JW; Kuhar MJ; Carroll FI
J Med Chem; 1996 Oct; 39(21):4139-41. PubMed ID: 8863789
[No Abstract] [Full Text] [Related]
40. Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle.
Loland CJ; Norregaard L; Litman T; Gether U
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1683-8. PubMed ID: 11818545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
